The lancet oncology
The most recent articles from:
Lancet Oncol.
-
The lancet oncology · Apr 2016
Randomized Controlled TrialAnamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trials.
Patients with advanced cancer frequently experience anorexia and cachexia, which are associated with reduced food intake, altered body composition, and decreased functionality. We assessed anamorelin, a novel ghrelin-receptor agonist, on cachexia in patients with advanced non-small-cell lung cancer and cachexia. ⋯ Helsinn Therapeutics.
-
The lancet oncology · Apr 2016
Multicenter Study Clinical Trial Observational StudyClinical effect of molecular methods in sarcoma diagnosis (GENSARC): a prospective, multicentre, observational study.
Advances in molecular genetics of sarcoma have enabled the identification of type-specific aberrations. We aimed to assess the clinical effect of systematic implementation of molecular assays to improve sarcoma misdiagnosis. ⋯ French National Cancer Institute and Nice University Hospital.